Thursday, February 14, 2013
Acorda Therapeutics Inc., of Ardsley, N.Y., beat analyst estimates with its net revenues hitting $81.5 million for the fourth quarter vs. the $79.8 million consensus. The company reported GAAP net income of $133 million for the quarter ended Dec. 31, 2012, or $3.27 per diluted EPS.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.